AAAAAA
Results:
1-7
|
Results: 7
Authors:
Druker, B
Citation: B. Druker, Signal transduction inhibition: Results from phase I clinical trials in chronic myeloid leukemia, SEM HEMATOL, 38(3), 2001, pp. 9-14
Authors:
Joensuu, H
Roberts, PJ
Sarlomo-Rikala, M
Andersson, LC
Tervahartiala, P
Tuveson, D
Silberman, SL
Capdeville, R
Dimitrijevic, S
Druker, B
Demetri, GD
Citation: H. Joensuu et al., Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor., N ENG J MED, 344(14), 2001, pp. 1052-1056
Authors:
Ota, S
Hazeki, K
Rao, N
Lupher, ML
Andoniou, CE
Druker, B
Band, H
Citation: S. Ota et al., The RING finger domain of Cbl is essential for negative regulation of the Syk tyrosine kinase (vol 275, pg 414, 2000), J BIOL CHEM, 275(8), 2000, pp. 6046-6046
Authors:
Ota, S
Hazeki, K
Rao, N
Lupher, ML
Andoniou, CE
Druker, B
Band, H
Citation: S. Ota et al., The RING finger domain of Cbl is essential for negative regulation of the Syk tyrosine kinase, J BIOL CHEM, 275(1), 2000, pp. 414-422
Authors:
Sawyers, CL
Druker, B
Citation: Cl. Sawyers et B. Druker, Tyrosine kinase inhibitors in chronic myeloid leukemia, CA J SCI AM, 5(2), 1999, pp. 63-69
Authors:
Tomasson, MH
Williams, IR
Hasserjian, R
Udomsakdi, C
McGrath, SM
Schwaller, J
Druker, B
Gilliland, DG
Citation: Mh. Tomasson et al., TEL/PDGF beta R induces hematologic malignancies in mice that respond to aspecific tyrosine kinase inhibitor, BLOOD, 93(5), 1999, pp. 1707-1714
Authors:
Lupher, ML
Rao, N
Lill, NL
Andoniou, CE
Miyake, S
Clark, EA
Druker, B
Band, H
Citation: Ml. Lupher et al., Cbl-mediated negative regulation of the Syk tyrosine kinase - A critical role for Cbl phosphotyrosine-binding domain binding to Syk phosphotyrosine 323, J BIOL CHEM, 273(52), 1998, pp. 35273-35281
Risultati:
1-7
|